Bordetella pertussis and Pertussis Vaccines

Clinical Infectious Diseases

Volumn 49, Issue 10, 2009, Pages 1565-1569

  Guiso, Nicole ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

BACTERIAL GENOME; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MORBIDITY; NONHUMAN; PATHOGENESIS; PERTUSSIS; PRIORITY JOURNAL; REVIEW; VACCINATION;

HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; PERTUSSIS VACCINE; VACCINATION; WHOOPING COUGH;

EID: 72849149644     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/644733     Document Type: Review

References (34)

1. Bordet J, Gengou O. Le microbe de la coqueluche. Annales de lInstitut Pasteur 1906; 20:731-741
2. Bordet J, Gengou O. Note complémentaire sur le microbe de la coqueluche. Annales de lInstitut Pasteur 1907; 21:720-726
3. Leslie PH, Gardner AD. The phases of Haemophilus pertussis. J Hyg Camb 1931; 31:423-434
4. Stibitz F. The bvg regulon. In: Camille Locht INSERM U629 and Institut Pasteur de Lille F, ed. Bordetella: molecular microbiology. Norfolk, UK: Horizon Bioscience, 2007:47-67.
5. Beier D, Gross R. The BvgS/BvgA phosphorelay system of pathogenic Bordetellae: structure, function and evolution. Adv Exp Med Biol 2008; 631:149-160
6. Bordet J, Sleeswyk. Sérodiagnostic et variabilité des microbes suivant le milieu de culture. Annales de lInstitut Pasteur 1910; 24:476-493
7. Lapin JH. Whooping cough. In: Thomas CC, ed. Whooping cough. Springfield, IL 1943:1-238.
8. Rosen de Rosenstein N. Traite des maladies des enfants. Montpellier: Tournel Joseph-François, père et fils, 1792.
9. Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Nat Genet 2003; 35:32-40.
10. Preston A, Temple L, Sebaihia M, Parkhill J, Maskell DJ. Speciation in the genus Bordetella as deduced from comparative genome analyses. In: Camille Locht INSERM U629 and Institut Pasteur de Lille F, ed. Bordetella: molecular microbiology. Norfolk, UK: Horizon Bioscience, 2007:1-15.
11. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 2005; 1:e45.
12. Mooi FR, He Q, Guiso N. Phylogeny, evolution, and epidemiology of bordetellae. In: Camille Locht INSERM U629 and Institut Pasteur de Lille F, ed. Bordetella: molecular microbiology. Norfolk, UK: Horizon Bioscience, 2007:17-45.
13. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326-382 (Pubitemid 40548297) (Pubitemid 40548297)
14. Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. Polymorphism of Bordetella pertussis isolates circulating the last ten years in France, where a single effective whole-cell vaccine has been used for more than thirty years. J Clin Microbiol 2001; 39:4396-4403
15. Caro V, Bouchez V, Guiso N, Gatti B, Agosti MR, Ayala SE. Pertussis in Argentina and France. Vaccine 2007; 25:4335-4339
16. Lazri M, Caro V, Brun D, et al. Pertussis in Algeria: direct and indirect methods of diagnosis- Analysis of the circulating isolates. Eighth International Symposium- Saga of the Genus Bordetella. CIS, Institut Pasteur, Paris, 2006.
17. Caro V, Elomaa A, Brun D, Mertsola J, He Q, Guiso N. Bordetella pertussis, Finland and France. Emerg Infect Dis 2006; 12:987-989
18. Njamkepo E, Guillemot L, Guiso N. Is Bordetella pertussis and parapertussis pathogenicity changing [abstract E1-10]? In: Program and abstracts of the 8th International Symposium-Saga of the Genus Bordetella (Paris). Paris: CIS, Institut Pasteur, 2006.
19. Bouchez V, Caro V, Levillain E, Guigon G, Guiso N. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE 2008; 3:e2437.
20. Dalet K,Weber C, Guillemot L, Njamkepo E, Guiso N. Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate. Infect Immun 2004; 72:4874-4877 (Pubitemid 38989349)
21. Soubeyrand B, Plotkin SA. Microbial evolution: antitoxin vaccines and pathogen virulence. Nature 2002; 417(6889):609-610; discussion 10.
22. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine. 2009; 27:6034-6041
23. Calendrier vaccinal 1998. Avis du Conseil supérieur dhygiène publique de France. BEH 1998; 15:61-62 Available at http://www.invs.sante.fr/beh/1998/9815/beh-15-1998.pdf.
24. Calendrier vaccinal 2004. Avis du Conseil supérieur dhygiène publique de France. BEH 2004; 28-29:121-132 Available at http://www.invs.sante.fr/beh/2004/28-29/beh-28-29-2004.pdf.
25. Calendrier vaccinal 2008- Avis du Haut conseil de la santé publique. Bull Epidemiol Heb 2008; 16-17:1-20. Available at http://www.invs. sante.fr/beh/2008/16-17/beh-16-17-2008.pdf.
26. Calendrier vaccinal 2009- Avis du Haut conseil de la santé publique. Bull Epidemiol Heb 2009; 16:1-20. Available at http://www.invs.sante. fr/beh/2009/16-17/beh-16-17-2009.pdf.
27. Khelef N, Danve B, Quentin-Millet MJ, Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 1993; 61:486-490
28. Wolfe DN, Goebel EM, Bjornstad ON, Restif O, Harvill ET. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussisinduced immunity. Infect Immun 2007; 75:4972-4979
29. He QS, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998; 280:635-637
30. Kourova N, Caro V, Weber C, et al. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J Clin Microbiol 2003; 41:3706-3711
31. Wharton M, Vitek CR. Diphtheria toxoid. In: Plotkin S, Orenstein, WA, Offit PA, eds. Vaccines. Vol 13. 4th ed. Philadelphia: Saunders, 2004: 211-228
32. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007; 25:2634-2642 (Pubitemid 46400927) (Pubitemid 46400927)
33. Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57(RR-4):1-51.
34. Riffelmann M, Littmann M, Hulsse C, Hellenbrand W, Wirsing von Konig CH. Pertussis: not only a disease of childhood. Dtsch Arztebl Int 2008; 105:623-628